{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:38Z","timestamp":1786114898539,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.braindev.2026.104574","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:08:48Z","timestamp":1784563728000},"page":"104574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vigabatrin therapy for infantile epileptic spasms syndrome with periventricular leukomalacia"],"prefix":"10.1016","volume":"48","author":[{"given":"Azusa","family":"Oba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhito","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Koichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Kanbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2026.104574_bb0005","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0010","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/brain\/awab162","article-title":"Early childhood epilepsies: epidemiology, classification, etiology, and socio-economic determinants","volume":"144","author":"Symonds","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2026.104574_bb0015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Report of the guideline development Subcommittee of the American Academy of neurology and the practice Committee of the Child Neurology Society","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2026.104574_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/adc.85.6.469","article-title":"Vigabatrin associated retinal dysfunction in children with epilepsy","volume":"85","author":"Koul","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.braindev.2026.104574_bb0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/epi.13836","article-title":"Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy","volume":"58","author":"Jackson","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/0883073813490073","article-title":"Electroretinographic responses in epileptic children treated with vigabatrin","volume":"29","author":"Bakhshandeh Bali","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2026.104574_bb0035","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.0000000000001069","article-title":"Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study","volume":"83","author":"Westall","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2026.104574_bb0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0883073807302599","article-title":"Factors associated with epilepsy in children with periventricular leukomalacia","volume":"22","author":"Humphreys","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2026.104574_bb0050","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.clineuro.2013.06.014","article-title":"Epilepsy in children with periventricular leukomalacia","volume":"115","author":"Ekici","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2026.104574_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.52.2.341","article-title":"Periventricular leukomalacia and epilepsy: incidence and seizure pattern","volume":"52","author":"Gurses","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2026.104574_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.seizure.2023.05.012","article-title":"Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia","volume":"109","author":"Matsuura","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2026.104574_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pedneo.2013.04.006","article-title":"Neurodevelopmental outcomes of children with periventricular leukomalacia","volume":"54","author":"Imamura","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.braindev.2026.104574_bb0070","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/epi.12847","article-title":"Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients","volume":"55","author":"Djuric","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"Pediatric epilepsy research consortium. Response to treatment in a prospective national infantile spasms cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2026.104574_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2015.04.012","article-title":"Vigabatrin as first-line treatment for infantile spasms not related to tuberous sclerosis complex","volume":"53","author":"Jones","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2026.104574_bb0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1528-1167.2010.02963.x","article-title":"Seizure outcome in infantile spasms--a retrospective study","volume":"52","author":"Mohamed","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0404.2011.01599.x","article-title":"Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing","volume":"192","author":"Carmant","year":"2011","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.braindev.2026.104574_bb0095","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","article-title":"Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104574_bb0100","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1177\/0883073810365103","article-title":"Vigabatrin for the treatment of infantile spasms: final report of a randomized trial","volume":"25","author":"Elterman","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2026.104574_bb0105","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2026.104574_bb0110","first-page":"35","article-title":"Periventricular leukomalacia","volume":"77","author":"Kidokoro","year":"2024","journal-title":"Shonika Rinsho"},{"key":"10.1016\/j.braindev.2026.104574_bb0115","first-page":"276","article-title":"Vigabatrin","volume":"36","author":"Kagitani-Shimono","year":"2019","journal-title":"Neuro-ophthalmol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:35:03Z","timestamp":1785969303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760426000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0387760426000756"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104574","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vigabatrin therapy for infantile epileptic spasms syndrome with periventricular leukomalacia","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104574"}}